Guangdong Tai'an Tang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Special Reminder:
- The Company's stock will be delisted on the trading day following the end of the delisting period.
- The start date for the delisting period is June 14, 2024, lasting for fifteen trading days, with the last trading day expected to be July 4, 2024.
- Investors, securities companies, and other market participants should settle stock pledge repurchase, agreed repurchase, margin financing, transfer, and Shenzhen Stock Connect transactions before the stock is delisted.
- For judicial freeze transactions expiring after the stock is delisted and before the completion of the initial registration in the delisting sector, it is recommended that the competent authorities handle the renewal procedures in advance through the original enforcement channels before the stock is delisted.